Omega Alpha

Fusion Pharmaceuticals

This clinical-stage biopharmaceutical company develops targeted alpha-particle radiopharmaceuticals for cancer patients and was acquired by AstraZeneca.

Albion VCTs

This company provides venture capital trust investment funds for retail investors seeking tax-efficient exposure to early-stage British technology and healthcare businesses.

Biomed

This venture capital firm provides investment funding for early-stage life science and biotechnology companies developing therapeutics in continental Europe.

XOMA Royalty

This company acquires economic rights to future milestone and royalty payments to provide non-dilutive capital for biotechnology and pharmaceutical developers.

BB Biotech AG

This investment company provides a portfolio of shares in biotechnology firms to retail and professional investors through its listing on several stock exchanges.

Pharos IBT

This company develops artificial intelligence platforms for discovering and developing treatments for rare and refractory diseases for the pharmaceutical and biotechnology industries.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Aktis Oncology

This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.